Somatic genetic aberrations in benign breast disease and the risk of subsequent breast cancer

NPJ Breast Cancer
Zexian ZengSusan E Clare

Abstract

It is largely unknown how the development of breast cancer (BC) is transduced by somatic genetic alterations in the benign breast. Since benign breast disease is an established risk factor for BC, we established a case-control study of women with a history of benign breast biopsy (BBB). Cases developed BC at least one year after BBB and controls did not develop BC over an average of 17 years following BBB. 135 cases were matched to 69 controls by age and type of benign change: non-proliferative or proliferation without atypia (PDWA). Whole-exome sequencing (WES) was performed for the BBB. Germline DNA (available from n = 26 participants) was utilized to develop a mutation-calling pipeline, to allow differentiation of somatic from germline variants. Among the 204 subjects, two known mutational signatures were identified, along with a currently uncatalogued signature that was significantly associated with triple negative BC (TNBC) (p = 0.007). The uncatalogued mutational signature was validated in 109 TNBCs from TCGA (p = 0.001). Compared to non-proliferative samples, PDWA harbors more abundant mutations at PIK3CA pH1047R (p < 0.001). Among the 26 BBB whose somatic copy number variation could be assessed, deletion of MLH3 is sign...Continue Reading

References

Jan 17, 1985·The New England Journal of Medicine·W D Dupont, D L Page
Apr 20, 2001·Biological Chemistry·F G Hanisch
Mar 22, 2002·Nature Reviews. Cancer·A G Knudson
Jun 14, 2002·Current Biology : CB·Claudia ColussiMargherita Bignami
Jan 16, 2003·Cell·Anne M CasperThomas W Glover
Jul 22, 2005·The New England Journal of Medicine·Lynn C HartmannDaniel W Visscher
Nov 15, 2007·Journal of the National Cancer Institute·Rowan T ChlebowskiWomen's Health Initiative Investigators
Feb 16, 2008·Nucleic Acids Research·Zachary F PursellThomas A Kunkel
Jul 3, 2008·Nature Reviews. Molecular Cell Biology·Karlene A Cimprich, David Cortez
Oct 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V Shane PankratzJudy C Boughey
Apr 11, 2009·Nature·Michael R StrattonP Andrew Futreal
Oct 6, 2009·Journal of the American College of Surgeons·Melvin J SilversteinShawna C Willey
Jan 19, 2010·Bioinformatics·Heng Li, Richard Durbin
Jul 6, 2010·Nucleic Acids Research·Kai WangHakon Hakonarson
Jul 8, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Judy C BougheyV Shane Pankratz
Jul 21, 2010·Genetic Testing and Molecular Biomarkers·Sarah E FlanaganSian Ellard
Feb 12, 2013·Nature Biotechnology·Kristian CibulskisGad Getz
Jul 3, 2013·The Journal of Molecular Diagnostics : JMD·David H SpencerEric J Duncavage
Jul 16, 2013·Nature Genetics·Steven A RobertsDmitry A Gordenin
Aug 16, 2013·Nature·Ludmil B AlexandrovMichael R Stratton
Sep 28, 2013·Nature Genetics·Giovanni CirielloChris Sander
Oct 3, 2013·Scientific Reports·David TamboreroNuria Lopez-Bigas
May 14, 2014·Proceedings of the National Academy of Sciences of the United States of America·Nagarajan KannanConnie J Eaves
Nov 20, 2014·Nature·Bret D FreudenthalSamuel H Wilson
Jan 28, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V Shane PankratzLynn C Hartmann
May 20, 2015·Breast Cancer Research and Treatment·Savas D SoysalErgin Kilic
Nov 10, 2015·Nature Genetics·Ludmil B AlexandrovMichael R Stratton
May 3, 2016·Nature·Serena Nik-ZainalMichael R Stratton
Jun 9, 2016·Genome Biology·William McLarenFiona Cunningham
Oct 11, 2016·Nature Cell Biology·Thomas E BassDavid Cortez
Dec 16, 2016·JAMA Oncology·Rachel PearlmanOhio Colorectal Cancer Prevention Initiative Study Group
Mar 23, 2017·Nature·Young Seok JuMichael R Stratton
Jun 30, 2017·Genome Medicine·Irina KalatskayaLincoln Stein
Sep 15, 2017·Cancer Research·Helen DaviesSerena Nik-Zainal
Feb 2, 2018·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Pauline Robbe100,000 Genomes Project
May 12, 2018·Nature Communications·Daniel TemkoTrevor A Graham
Jun 7, 2018·British Journal of Cancer·Thomas E RohanElaine Mardis
Jul 10, 2018·Nature Communications·Daniel MartinJ Silvio Gutkind
Mar 1, 2019·Annals of Surgical Oncology·Meghan R FlanaganMelissa L Pilewskie
Jun 14, 2019·Nature Communications·Yogita SharmaSven Diederichs
Aug 10, 2019·Frontiers in Medicine·Savas D SoysalSimone Muenst
Dec 13, 2019·Nature Communications·Youli XiaCharles M Perou

Citations

Sep 17, 2020·Cancer Research·Poornima Bhat-NakshatriHarikrishna Nakshatri

Related Concepts

Breast
Malignant Neoplasm of Breast
Malignant Neoplasms
Case-Control Studies
Cell Differentiation Process
DNA
Breast Fibrocystic Disease
Gene Deletion
Woman
Somatization

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.